© ASUASU researchers Qiang "Shawn " Chen and Huafang "Lily " Lai infiltrate a tobacco plant to produce monoclonal antibodies against West Nile virus.
An international research group led by Arizona State University professor Qiang "Shawn" Chen has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus, and other pathogens.
The therapeutics, known as monoclonal antibodies (MAbs) and their derivatives, were shown to neutralize and protect mice against a lethal dose challenge of West Nile virus---even as late as 4 days after the initial infection.
"The overarching goal of our research is to create an innovative, yet sustainable and accessible, low cost solution to combat the global threat of West Nile virus," said Chen, a researcher at Arizona State University's Biodesign Institute and professor in the Department of TEIM.
West Nile virus is spread by infected mosquitoes, and targets the central nervous system. It can be a serious, life-altering and even fatal disease and currently, there is no cure or drug treatment against West Nile virus, which has been widely spread across the U.S., Canada, Latin America and the Caribbean.
Comment: Give the 'mentally ill' a break. After all, they need something to counteract the zombie-fying effects of antipsychotic medicines.
For more on the benefits of smoking (ideally organic or additive free natural tobacco) see:
5 Health Benefits of Smoking
Health Benefits of Smoking Tobacco
Nicotine Benefits